Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion type Assertion NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_head.
- NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion description "[These results suggest that OCIAD2 begins to express at the progression from in situ to invasive carcinoma, and is associated with the favorable prognosis of adenocarcinoma mixed subtype with BAC component.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_provenance.
- NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion evidence source_evidence_literature NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_provenance.
- NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion SIO_000772 17054434 NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_provenance.
- NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion wasDerivedFrom befree-20150227 NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_provenance.
- NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_assertion wasGeneratedBy ECO_0000203 NP970936.RAR4FBZFRD3afWF9nFuMTAjYQqO4U7rGd9dLZp7GYoxB8130_provenance.